US Archives - Page 4 of 129 - European Medical Journal

AMJ Podcast | Episode 2: Inside the MDT: Expert Voices in Muscle-Invasive Bladder Cancer Care

How do urologists, oncologists, and advanced practice providers coordinate care in muscle-invasive bladder cancer…

Menopause Modifies Impact of Vaginal Birth on Urinary Incontinence

Vaginal delivery increases the likelihood of stress and mixed urinary incontinence in women, with risk patterns differing before and after natural menopause.

Autism Care Gaps Persist Between US and Global Communities

Autism spectrum disorder (ASD) is rising worldwide, yet major differences in diagnosis and access to care highlight persistent disparities between the United States and other regions.

Cancer Prevention Through Surgery Brings Menopause Forward

Women with hereditary cancer syndromes face complex decisions that weigh the benefits of ovarian cancer prevention against the potential long-term risks of cardiovascular disease.

Omega-3s Reduce Inflammation but Not Outcomes in Head Injuries

Omega-3 supplementation reduced key markers of inflammation and oxidative stress in patients with moderate-to-severe head injuries but failed to translate into improved long-term clinical outcomes.

Indoor Wood Burning in Affluent Areas Problematic for Lung Health

Indoor wood burning is increasingly linked to declining lung function, with new findings suggesting a rising public health threat in Europe.

Why No Ideal Sepsis Tool Exists

Sepsis remains a medical emergency, but a new narrative review finds that no single screening tool reliably diagnoses it.

New Algorithm Forecasts NSAID Efficacy for Knee Pain

Machine learning models can accurately predict which patients with painful knee osteoarthritis will benefit from short-term NSAID plus paracetamol therapy, according to new research.

Supersized US Drinks and Salty Snacks Flag Health Concerns

In a first-of-its-kind cross-national assessment, researchers compared the nutritional content and “healthiness” of sweet and salty snacks and beverages in South Korea and the United States using standard nutrition labels.

Can Biologic Therapy Be Safely Used in HS?

Adalimumab use in patients with hidradenitis suppurativa (HS) appears safe with appropriate prophylaxis, as no cases of hepatitis B virus (HBV) or tuberculosis (TB) reactivation were observed in a large retrospective analysis.